Anterix (ATEX) Financials

$29.24 -0.60 (-2.01%)

As of 11:25 AM Eastern

Annual Income Statements for Anterix

This table shows Anterix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	3/31/2022	3/31/2023	3/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-38	-16	-9.13
Consolidated Net Income / (Loss)	-38	-16	-9.13
Net Income / (Loss) Continuing Operations	-38	-16	-9.13
Total Pre-Tax Income	-37	-15	-7.52
Total Operating Income	-37	-16	-10
Total Gross Profit	1.08	1.92	4.19
Total Revenue	1.08	1.92	4.19
Operating Revenue	1.08	1.92	4.19
Total Cost of Revenue	0.01	0.00	0.00
Total Operating Expenses	38	18	14
Selling, General & Admin Expense	40	45	44
Marketing Expense	4.46	5.73	5.69
Research & Development Expense	3.59	4.44	5.70
Depreciation Expense	1.45	1.42	0.84
Other Special Charges / (Income)	-11	-38	-42
Total Other Income / (Expense), net	0.31	1.41	2.61
Interest & Investment Income	0.06	1.14	2.37
Other Income / (Expense), net	0.26	0.27	0.23
Income Tax Expense	0.98	1.26	1.61
Basic Earnings per Share	($2.07)	($0.87)	($0.49)
Weighted Average Basic Shares Outstanding	18.14M	18.84M	18.77M
Diluted Earnings per Share	($2.07)	($0.87)	($0.49)
Weighted Average Diluted Shares Outstanding	18.14M	18.84M	18.77M
Weighted Average Basic & Diluted Shares Outstanding	18.93M	19.04M	18.57M

This table shows Anterix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	12/31/2021	3/31/2022	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2024	9/30/2023	12/31/2024	3/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-13	-11	-13	-11	-8.02	16	-16	2.07	7.71	-9.41
Consolidated Net Income / (Loss)	-13	-11	-13	-11	-8.02	16	-16	2.07	7.71	-9.41
Net Income / (Loss) Continuing Operations	-13	-11	-13	-11	-8.02	16	-16	2.07	7.71	-9.41
Total Pre-Tax Income	-12	-11	-13	-10	-7.81	16	-14	2.72	7.48	-9.54
Total Operating Income	-12	-11	-13	-11	-8.40	16	-15	2.26	7.03	-11
Total Gross Profit	0.38	0.34	0.34	0.40	0.58	0.61	1.53	1.05	1.57	1.26
Total Revenue	0.39	0.34	0.34	0.40	0.58	0.61	1.53	1.05	1.57	1.26
Operating Revenue	0.39	0.34	0.34	0.40	0.58	0.61	1.53	1.05	1.57	1.26
Total Operating Expenses	13	11	13	11	8.98	-15	17	-1.21	-5.47	12
Selling, General & Admin Expense	10	9.75	11	11	12	10	13	12	9.20	9.59
Marketing Expense	1.26	1.15	1.24	1.16	1.39	1.95	1.85	1.31	1.31	1.73
Research & Development Expense	0.89	0.77	1.10	0.98	0.94	1.43	1.75	1.15	1.12	2.24
Depreciation Expense	0.32	0.45	0.36	0.37	0.37	0.31	0.18	0.21	0.14	0.19
Other Special Charges / (Income)	0.06	-0.98	-0.65	-2.89	-5.80	-29	-	-16	-21	-1.98
Total Other Income / (Expense), net	0.07	0.06	0.08	0.23	0.59	0.50	0.71	0.46	0.44	0.97
Interest & Investment Income	0.01	0.00	0.02	0.24	0.41	0.47	0.69	0.40	0.43	0.93
Other Income / (Expense), net	0.06	0.06	0.06	-0.01	0.19	0.03	0.02	0.06	0.01	0.04
Income Tax Expense	0.41	0.27	0.20	0.22	0.21	0.64	1.22	0.65	-0.23	-0.13
Basic Earnings per Share	($0.69)	($0.60)	($0.71)	($0.56)	($0.42)	$0.82	($0.84)	$0.11	$0.41	($0.51)
Weighted Average Basic Shares Outstanding	18.31M	18.14M	18.62M	18.95M	18.93M	18.84M	18.49M	18.92M	18.61M	18.77M
Diluted Earnings per Share	($0.69)	($0.60)	($0.71)	($0.56)	($0.42)	$0.82	($0.84)	$0.11	$0.41	($0.51)
Weighted Average Diluted Shares Outstanding	18.31M	18.14M	18.62M	18.95M	18.93M	18.84M	18.49M	19.11M	18.78M	18.77M
Weighted Average Basic & Diluted Shares Outstanding	18.31M	18.93M	18.94M	18.96M	18.87M	19.04M	18.59M	18.62M	18.59M	18.57M

This table details how cash moves in and out of Anterix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	3/31/2022	3/31/2023	3/31/2024
Net Change in Cash & Equivalents	-12	-62	25
Net Cash From Operating Activities	18	-27	42
Net Cash From Continuing Operating Activities	18	-27	42
Net Income / (Loss) Continuing Operations	-38	-16	-9.13
Consolidated Net Income / (Loss)	-38	-16	-9.13
Depreciation Expense	1.45	1.42	0.84
Non-Cash Adjustments To Reconcile Net Income	2.16	-20	-28
Changes in Operating Assets and Liabilities, net	52	8.12	78
Net Cash From Investing Activities	-27	-27	8.09
Net Cash From Continuing Investing Activities	-27	-27	8.09
Purchase of Property, Plant & Equipment	-1.05	-2.13	-0.31
Acquisitions	-26	-25	-17
Divestitures	-	0.00	25
Net Cash From Financing Activities	-2.42	-8.06	-25
Net Cash From Continuing Financing Activities	-2.42	-8.06	-25
Repurchase of Common Equity	-15	-8.22	-25
Other Financing Activities, net	13	0.16	-0.46

This table details how cash moves in and out of Anterix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	12/31/2021	3/31/2022	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024
Net Change in Cash & Equivalents	27	-22	-19	-16	-13	-14	-14	14	21	-1.43
Net Cash From Operating Activities	40	-9.12	-9.83	-8.12	-0.73	-8.57	-8.21	4.57	34	6.14
Net Cash From Continuing Operating Activities	40	-9.12	-9.83	-8.12	-0.73	-8.57	-8.21	4.57	34	6.14
Net Income / (Loss) Continuing Operations	-13	-11	-13	-11	-8.02	16	-2.12	15	0.33	-9.41
Consolidated Net Income / (Loss)	-13	-11	-13	-11	-8.02	16	-2.12	15	0.33	-9.41
Depreciation Expense	0.32	0.45	0.36	0.37	0.37	0.31	0.25	0.28	0.20	0.19
Non-Cash Adjustments To Reconcile Net Income	3.28	3.31	3.18	1.93	-1.29	-24	-7.19	-23	-9.95	1.40
Changes in Operating Assets and Liabilities, net	48	-1.03	-0.42	0.47	8.21	-0.15	0.85	12	43	14
Net Cash From Investing Activities	-4.21	-11	-6.66	-5.72	-8.24	-6.52	-5.20	20	-4.54	-2.26
Net Cash From Continuing Investing Activities	-4.21	-11	-6.66	-5.72	-8.24	-6.52	-5.20	20	-4.54	-2.26
Purchase of Property, Plant & Equipment	-0.04	-0.80	-0.01	-1.14	-0.40	-0.58	-0.03	-0.21	-0.06	-0.04
Acquisitions	-4.16	-10	-6.65	-4.58	-7.84	-5.94	-5.17	-4.68	-4.73	-2.22
Net Cash From Financing Activities	-8.53	-1.89	-2.68	-2.51	-3.64	0.76	-0.75	-11	-8.09	-5.30
Net Cash From Continuing Financing Activities	-8.53	-1.89	-2.68	-2.51	-3.64	0.76	-0.75	-11	-8.09	-5.30
Repurchase of Common Equity	-12	-2.97	-2.73	-2.00	-3.50	-	0.00	-8.71	-7.97	-5.97
Other Financing Activities, net	3.47	1.08	0.05	-0.51	-0.14	0.76	-0.75	-1.97	-0.12	0.67

This table presents Anterix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	3/31/2022	3/31/2023	3/31/2024
Total Assets	278	279	325
Total Current Assets	116	59	73
Cash & Equivalents	106	43	61
Prepaid Expenses	10	2.44	3.91
Other Current Assets	-	14	8.52
Plant, Property, & Equipment, net	2.95	3.61	2.06
Total Noncurrent Assets	159	215	250
Intangible Assets	151	202	217
Other Noncurrent Operating Assets	8.16	13	33
Total Liabilities & Shareholders' Equity	278	279	325
Total Liabilities	92	99	164
Total Current Liabilities	9.64	32	18
Short-Term Debt	0.00	20	1.00
Accounts Payable	6.65	6.62	8.63
Accrued Expenses	-	-	0.00
Current Deferred Revenue	1.48	2.77	6.47
Other Current Liabilities	1.51	2.26	1.85
Total Noncurrent Liabilities	82	67	146
Noncurrent Deferred Revenue	53	58	116
Noncurrent Deferred & Payable Income Tax Liabilities	4.19	5.44	6.28
Other Noncurrent Operating Liabilities	25	3.44	24
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	186	180	161
Total Preferred & Common Equity	186	180	161
Preferred Stock	0.00	0.00	0.00
Total Common Equity	186	180	161
Common Stock	500	518	533
Retained Earnings	-314	-338	-372

This table presents Anterix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	12/31/2021	6/30/2022	9/30/2022	12/31/2022	6/30/2024	9/30/2024	12/31/2024
Total Assets	288	264	256	258	321	317	327
Total Current Assets	135	98	82	72	66	57	40
Cash & Equivalents	128	86	70	58	52	43	29
Prepaid Expenses	7.27	12	12	15	2.97	1.58	3.14
Other Current Assets	-	-	-	-	11	12	8.35
Plant, Property, & Equipment, net	2.64	2.59	3.32	3.34	1.84	1.73	1.58
Total Noncurrent Assets	150	163	171	182	254	259	285
Intangible Assets	144	155	159	170	220	222	246
Other Noncurrent Operating Assets	5.93	8.60	11	12	34	37	39
Total Liabilities & Shareholders' Equity	288	264	256	258	321	317	327
Total Liabilities	92	90	90	99	172	178	182
Total Current Liabilities	9.87	8.97	30	31	17	16	24
Short-Term Debt	-	-	20	20	1.00	1.00	5.40
Accounts Payable	6.94	5.21	5.51	6.68	7.75	7.09	9.01
Accrued Expenses	-	-	-	-	-	-	2.29
Current Deferred Revenue	1.48	2.19	2.51	2.66	5.97	5.92	5.96
Other Current Liabilities	1.45	1.57	1.63	1.75	1.81	1.81	1.75
Total Noncurrent Liabilities	83	81	60	67	156	162	158
Noncurrent Deferred Revenue	54	52	51	59	115	121	120
Noncurrent Deferred & Payable Income Tax Liabilities	3.92	4.39	4.60	4.81	7.34	7.67	6.74
Other Noncurrent Operating Liabilities	25	24	3.92	3.73	34	34	31
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	196	175	166	159	149	139	145
Total Preferred & Common Equity	196	175	166	159	149	139	145
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	196	175	166	159	149	139	145
Common Stock	495	504	508	513	539	542	544
Retained Earnings	-300	-330	-342	-354	-390	-402	-399

This table displays calculated financial ratios and metrics derived from Anterix's official financial filings.

Metric	2022	2023	2024
Period end date	3/31/2022	3/31/2023	3/31/2024
Growth Metrics	-	-	-
Revenue Growth	17.70%	77.03%	118.40%
EBITDA Growth	30.91%	57.96%	38.78%
EBIT Growth	32.73%	55.74%	38.94%
NOPAT Growth	32.77%	55.33%	38.51%
Net Income Growth	31.07%	56.51%	44.06%
EPS Growth	33.87%	57.97%	43.68%
Operating Cash Flow Growth	279.87%	-252.12%	254.10%
Free Cash Flow Firm Growth	55.37%	-662.84%	155.09%
Invested Capital Growth	-15.05%	94.44%	-35.32%
Revenue Q/Q Growth	54.42%	16.59%	18.42%
EBITDA Q/Q Growth	2.02%	64.04%	-152.43%
EBIT Q/Q Growth	1.04%	62.03%	-160.72%
NOPAT Q/Q Growth	1.10%	61.67%	-150.74%
Net Income Q/Q Growth	-0.22%	61.94%	-157.68%
EPS Q/Q Growth	0.96%	62.01%	-158.33%
Operating Cash Flow Q/Q Growth	-52.54%	1.98%	53.94%
Free Cash Flow Firm Q/Q Growth	-168.74%	-4.46%	97.26%
Invested Capital Q/Q Growth	18.88%	28.82%	-8.79%
Profitability Metrics	-	-	-
Gross Margin	99.54%	100.00%	100.00%
EBITDA Margin	-3,241.88%	-769.93%	-215.82%
Operating Margin	-3,399.26%	-857.79%	-241.52%
EBIT Margin	-3,375.65%	-843.93%	-235.96%
Profit (Net Income) Margin	-3,461.16%	-850.29%	-217.80%
Tax Burden Percent	102.69%	108.38%	121.46%
Interest Burden Percent	99.85%	92.96%	75.99%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-29.37%	-9.70%	-5.49%
ROIC Less NNEP Spread (ROIC-NNEP)	-18.86%	-2.24%	-0.53%
Return on Net Nonoperating Assets (RNNOA)	10.55%	0.79%	0.13%
Return on Equity (ROE)	-18.82%	-8.91%	-5.36%
Cash Return on Invested Capital (CROIC)	-13.09%	-73.85%	37.41%
Operating Return on Assets (OROA)	-13.78%	-5.82%	-3.28%
Return on Assets (ROA)	-14.13%	-5.86%	-3.03%
Return on Common Equity (ROCE)	-18.82%	-8.91%	-5.36%
Return on Equity Simple (ROE_SIMPLE)	-20.14%	-9.08%	-5.67%
Net Operating Profit after Tax (NOPAT)	-26	-12	-7.09
NOPAT Margin	-2,379.48%	-600.45%	-169.06%
Net Nonoperating Expense Percent (NNEP)	-10.51%	-7.46%	-4.95%
Cost of Revenue to Revenue	0.46%	0.00%	0.00%
SG&A Expenses to Revenue	3,646.22%	2,354.19%	1,059.96%
R&D to Revenue	331.46%	231.32%	135.93%
Operating Expenses to Revenue	3,498.80%	957.79%	341.52%
Earnings before Interest and Taxes (EBIT)	-37	-16	-9.89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-35	-15	-9.05
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	5.71	3.47	3.87
Price to Tangible Book Value (P/TBV)	30.29	0.00	0.00
Price to Revenue (P/Rev)	981.47	324.87	148.52
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	11.88	3.83	5.55
Enterprise Value to Revenue (EV/Rev)	884.03	312.92	134.31
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	53.50	0.00	13.40
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	11.65
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.11	0.01
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.56	-0.35	-0.24
Leverage Ratio	1.33	1.52	1.77
Compound Leverage Factor	1.33	1.41	1.35
Debt to Total Capital	0.00%	10.12%	0.62%
Short-Term Debt to Total Capital	0.00%	10.12%	0.62%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	89.88%	99.38%
Debt to EBITDA	0.00	-1.37	-0.11
Net Debt to EBITDA	0.00	1.55	6.59
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	0.00	-1.76	-0.14
Net Debt to NOPAT	0.00	1.99	8.41
Long-Term Debt to NOPAT	0.00	0.00	0.00
Altman Z-Score	5.41	2.02	0.79
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	12.01	1.86	4.07
Quick Ratio	10.96	1.35	3.37
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-11	-88	48
Operating Cash Flow to CapEx	1,701.14%	-1,281.75%	13,678.50%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.00	0.01	0.01
Accounts Receivable Turnover	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.33	0.59	1.48
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	476,471.00	0.00	0.00
Cash Conversion Cycle (CCC)	-476,471.00	0.00	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	81	157	101
Invested Capital Turnover	0.01	0.02	0.03
Increase / (Decrease) in Invested Capital	-14	76	-55
Enterprise Value (EV)	958	600	563
Market Capitalization	1,064	623	622
Book Value per Share	$10.14	$9.53	$8.70
Tangible Book Value per Share	$1.91	($1.18)	($3.01)
Total Capital	186	200	162
Total Debt	0.00	20	1.00
Total Long-Term Debt	0.00	0.00	0.00
Net Debt	-106	-23	-60
Capital Expenditures (CapEx)	1.05	2.13	0.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.51	4.63	-4.52
Debt-free Net Working Capital (DFNWC)	106	48	56
Net Working Capital (NWC)	106	28	55
Net Nonoperating Expense (NNE)	12	4.79	2.04
Net Nonoperating Obligations (NNO)	-106	-23	-60
Total Depreciation and Amortization (D&A)	1.45	1.42	0.84
Debt-free, Cash-free Net Working Capital to Revenue	47.14%	241.06%	-107.80%
Debt-free Net Working Capital to Revenue	9,791.05%	2,491.30%	1,337.63%
Net Working Capital to Revenue	9,791.05%	1,436.11%	1,313.77%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($2.07)	($0.87)	($0.49)
Adjusted Weighted Average Basic Shares Outstanding	18.14M	18.84M	18.77M
Adjusted Diluted Earnings per Share	($2.07)	($0.87)	($0.49)
Adjusted Weighted Average Diluted Shares Outstanding	18.14M	18.84M	18.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	18.93M	19.04M	18.57M
Normalized Net Operating Profit after Tax (NOPAT)	-34	-38	-37
Normalized NOPAT Margin	-3,096.40%	-2,000.78%	-876.31%
Pre Tax Income Margin	-3,370.48%	-784.52%	-179.31%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-39.88%	-50.40%	-270.33%

This table displays calculated financial ratios and metrics derived from Anterix's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	12/31/2021	3/31/2022	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2024	9/30/2024	12/31/2024	3/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-18.43%	812.77%	84.07%	118.68%	50.13%	81.49%	355.22%	289.70%	170.93%	107.24%
EBITDA Growth	-7.22%	6.58%	-10.32%	-898.06%	33.07%	255.69%	-19.37%	-24.80%	192.28%	-164.14%
EBIT Growth	-2.99%	3.47%	-9.44%	-548.75%	33.24%	246.20%	-15.24%	-23.03%	185.68%	-166.63%
NOPAT Growth	-2.58%	3.65%	-9.28%	-524.49%	32.09%	299.10%	-14.84%	-23.17%	223.28%	-148.86%
Net Income Growth	-5.18%	-0.75%	-9.88%	-498.93%	36.92%	241.07%	-17.64%	-19.95%	196.13%	-160.55%
EPS Growth	0.00%	3.23%	-4.41%	-460.00%	39.13%	236.67%	-18.31%	-23.21%	197.62%	-162.20%
Operating Cash Flow Growth	768.51%	-185.19%	-1.75%	-177.09%	-101.84%	6.03%	75.99%	156.36%	4,720.88%	171.61%
Free Cash Flow Firm Growth	341.48%	41.61%	104.59%	-343.31%	-275.11%	-1,007.86%	-503.23%	189.59%	112.83%	178.60%
Invested Capital Growth	-38.68%	-15.05%	-13.91%	3.39%	79.43%	94.44%	11.32%	-16.60%	-0.34%	-35.32%
Revenue Q/Q Growth	111.54%	-12.99%	0.00%	18.81%	45.23%	5.19%	150.82%	155.10%	0.97%	-0.87%
EBITDA Q/Q Growth	-1,035.95%	12.22%	-20.62%	17.02%	23.83%	304.21%	-192.48%	-414.57%	156.32%	-957.76%
EBIT Q/Q Growth	-648.45%	12.73%	-21.11%	17.99%	22.99%	291.13%	-195.46%	-378.50%	153.63%	-1,146.70%
NOPAT Q/Q Growth	-624.96%	12.69%	-20.99%	18.45%	21.16%	355.96%	-169.79%	-362.49%	178.90%	-3,956.73%
Net Income Q/Q Growth	-615.53%	13.35%	-19.78%	19.35%	24.65%	293.79%	-199.88%	-502.74%	160.39%	-2,969.21%
EPS Q/Q Growth	-590.00%	13.04%	-18.33%	21.13%	25.00%	295.24%	-202.44%	-527.27%	159.42%	-2,650.00%
Operating Cash Flow Q/Q Growth	1,452.99%	-123.02%	-7.76%	17.45%	91.03%	-1,077.75%	72.46%	293.73%	635.46%	-81.75%
Free Cash Flow Firm Q/Q Growth	1,442.66%	-80.28%	-24.56%	-321.93%	-430.35%	-2.25%	66.49%	184.43%	-24.05%	348.10%
Invested Capital Q/Q Growth	-39.63%	18.88%	9.20%	31.93%	4.77%	28.82%	-37.48%	-1.16%	25.18%	-8.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	98.70%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-3,044.94%	-3,071.94%	-3,705.37%	-2,587.94%	-1,357.44%	2,635.20%	-971.61%	-828.76%	462.32%	-815.56%
Operating Margin	-3,214.29%	-3,225.07%	-3,902.09%	-2,678.39%	-1,453.98%	2,578.13%	-984.39%	-846.55%	449.04%	-834.21%
EBIT Margin	-3,197.92%	-3,207.46%	-3,884.48%	-2,681.41%	-1,421.97%	2,583.72%	-983.34%	-846.55%	449.68%	-830.71%
Profit (Net Income) Margin	-3,302.60%	-3,288.66%	-3,939.10%	-2,674.12%	-1,387.54%	2,556.25%	-1,017.97%	-823.08%	492.34%	-746.90%
Tax Burden Percent	103.35%	102.54%	101.54%	102.06%	102.69%	96.06%	108.54%	101.83%	103.13%	98.64%
Interest Burden Percent	99.93%	99.99%	99.87%	97.71%	95.02%	102.99%	95.37%	95.48%	106.16%	91.15%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	3.94%	0.00%	0.00%	-3.13%	0.00%
Return on Invested Capital (ROIC)	-17.70%	-27.87%	-35.49%	-23.83%	-17.67%	40.02%	-16.23%	-18.60%	14.61%	-18.95%
ROIC Less NNEP Spread (ROIC-NNEP)	-14.26%	-24.77%	-31.30%	-19.61%	-15.08%	39.26%	-8.91%	-10.83%	13.10%	-13.97%
Return on Net Nonoperating Assets (RNNOA)	8.13%	13.86%	15.77%	7.79%	7.02%	-13.79%	3.78%	3.26%	-2.62%	3.38%
Return on Equity (ROE)	-9.57%	-14.00%	-19.72%	-16.04%	-10.65%	26.23%	-12.45%	-15.33%	11.99%	-15.57%
Cash Return on Invested Capital (CROIC)	18.74%	-13.09%	-12.96%	-32.06%	-88.56%	-73.85%	-15.40%	12.39%	17.93%	37.41%
Operating Return on Assets (OROA)	-8.48%	-13.09%	-18.75%	-15.20%	-8.58%	17.82%	-7.36%	-9.88%	5.90%	-11.54%
Return on Assets (ROA)	-8.76%	-13.42%	-19.02%	-15.16%	-8.37%	17.63%	-7.62%	-9.61%	6.46%	-10.37%
Return on Common Equity (ROCE)	-9.57%	-14.00%	-19.72%	-16.04%	-10.65%	26.23%	-12.45%	-15.33%	11.99%	-15.57%
Return on Equity Simple (ROE_SIMPLE)	-19.14%	0.00%	-22.17%	-28.64%	-26.96%	0.00%	-3.52%	-5.29%	16.03%	0.00%
Net Operating Profit after Tax (NOPAT)	-8.66	-7.56	-9.15	-7.46	-5.88	15	-11	-9.19	7.25	-7.36
NOPAT Margin	-2,250.00%	-2,257.55%	-2,731.46%	-1,874.87%	-1,017.79%	2,476.62%	-689.08%	-592.59%	463.10%	-583.94%
Net Nonoperating Expense Percent (NNEP)	-3.43%	-3.10%	-4.18%	-4.22%	-2.59%	0.75%	-7.31%	-7.77%	1.51%	-4.98%
Cost of Revenue to Revenue	1.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	2,654.29%	2,910.75%	3,390.75%	2,871.11%	2,090.83%	1,695.07%	842.69%	734.82%	587.68%	761.35%
R&D to Revenue	231.95%	228.96%	327.16%	246.23%	161.94%	234.70%	114.75%	114.51%	71.52%	178.02%
Operating Expenses to Revenue	3,312.99%	3,325.07%	4,002.09%	2,778.39%	1,553.98%	-2,478.13%	1,090.49%	946.55%	-349.04%	934.21%
Earnings before Interest and Taxes (EBIT)	-12	-11	-13	-11	-8.22	16	-15	-13	7.04	-10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-12	-10	-12	-10	-7.85	16	-15	-13	7.24	-10
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.52	5.71	4.46	4.07	3.84	3.47	4.94	5.04	3.95	3.87
Price to Tangible Book Value (P/TBV)	21.09	30.29	39.53	102.22	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1,537.34	981.47	628.63	465.72	370.55	324.87	335.38	209.35	148.94	148.52
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	24.61	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.06%	0.00%
Enterprise Value to Invested Capital (EV/IC)	14.02	11.88	7.85	5.39	4.70	3.83	6.98	6.79	4.51	5.55
Enterprise Value to Revenue (EV/Rev)	1,355.34	884.03	558.74	431.40	347.92	312.92	312.25	196.76	142.83	134.31
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	23.51	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	24.53	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.61	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	25.21	53.50	38.95	49.92	0.00	0.00	0.00	0.00	20.07	13.40
Enterprise Value to Free Cash Flow (EV/FCFF)	56.89	0.00	0.00	0.00	0.00	0.00	0.00	49.85	25.12	11.65
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.12	0.13	0.11	0.01	0.01	0.04	0.01
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.56	-0.50	-0.40	-0.47	-0.35	-0.42	-0.30	-0.20	-0.24
Leverage Ratio	1.28	1.33	1.34	1.35	1.54	1.52	1.81	1.88	1.92	1.77
Compound Leverage Factor	1.27	1.33	1.33	1.32	1.46	1.57	1.73	1.79	2.04	1.61
Debt to Total Capital	0.00%	0.00%	0.00%	10.87%	11.30%	10.12%	0.67%	0.71%	3.59%	0.62%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	10.87%	11.30%	10.12%	0.67%	0.71%	3.59%	0.62%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	89.13%	88.71%	89.88%	99.33%	99.29%	96.41%	99.38%
Debt to EBITDA	0.00	0.00	0.00	-0.45	-0.49	-1.37	-0.21	-0.13	0.23	-0.11
Net Debt to EBITDA	0.00	0.00	0.00	1.10	0.91	1.55	10.82	5.57	-1.00	6.59
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	-0.62	-0.67	-1.76	-0.23	-0.16	0.25	-0.14
Net Debt to NOPAT	0.00	0.00	0.00	1.52	1.24	1.99	11.63	6.92	-1.09	8.41
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	5.93	5.71	3.69	2.76	1.88	2.40	0.90	0.61	0.31	0.79
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	13.68	12.01	10.96	2.74	2.31	1.86	3.98	3.59	1.65	4.07
Quick Ratio	12.94	10.96	9.64	2.34	1.84	1.35	3.13	2.73	1.18	3.37
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	34	6.73	5.08	-11	-60	-61	-20	10	7.67	48
Operating Cash Flow to CapEx	92,160.47%	-1,139.08%	-163,866.67%	-712.55%	-182.91%	-1,470.67%	0.00%	2,157.55%	61,163.64%	15,350.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.22	0.33	0.41	0.46	0.55	0.59	0.99	1.33	1.56	1.48
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	526,038.00	476,471.00	378,943.00	376,643.50	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	-526,038.00	-476,471.00	-378,943.00	-376,643.50	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	68	81	88	116	122	157	98	97	121	101
Invested Capital Turnover	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.03	0.03	0.03
Increase / (Decrease) in Invested Capital	-43	-14	-14	3.81	54	76	9.97	-19	-0.42	-55
Enterprise Value (EV)	951	958	691	627	573	600	684	658	548	563
Market Capitalization	1,079	1,064	778	677	610	623	735	700	571	622
Book Value per Share	$10.65	$10.14	$9.22	$8.77	$8.39	$9.53	$8.01	$7.48	$7.77	$8.70
Tangible Book Value per Share	$2.79	$1.91	$1.04	$0.35	($0.56)	($1.18)	($3.82)	($4.45)	($5.45)	($3.01)
Total Capital	196	186	175	186	179	200	150	140	150	162
Total Debt	0.00	0.00	0.00	20	20	20	1.00	1.00	5.40	1.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-128	-106	-86	-50	-37	-23	-51	-42	-23	-60
Capital Expenditures (CapEx)	0.04	0.80	0.01	1.14	0.40	0.58	0.00	0.21	0.06	0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.60	0.51	2.91	2.06	3.88	4.63	-1.55	-1.16	-7.52	-4.52
Debt-free Net Working Capital (DFNWC)	125	106	89	72	61	48	50	42	21	56
Net Working Capital (NWC)	125	106	89	52	41	28	49	41	16	55
Net Nonoperating Expense (NNE)	4.05	3.45	4.05	3.18	2.14	-0.48	5.02	3.58	-0.46	2.05
Net Nonoperating Obligations (NNO)	-128	-106	-86	-50	-37	-23	-51	-42	-23	-60
Total Depreciation and Amortization (D&A)	0.59	0.45	0.60	0.37	0.37	0.31	0.18	0.28	0.20	0.19
Debt-free, Cash-free Net Working Capital to Revenue	-370.80%	47.14%	235.00%	141.84%	235.42%	241.06%	-70.80%	-34.74%	-196.19%	-107.80%
Debt-free Net Working Capital to Revenue	17,829.20%	9,791.05%	7,224.17%	4,967.31%	3,729.40%	2,491.30%	2,288.46%	1,254.62%	554.90%	1,337.63%
Net Working Capital to Revenue	17,829.20%	9,791.05%	7,224.17%	3,573.71%	2,499.21%	1,436.11%	2,242.84%	1,224.72%	414.14%	1,313.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.69)	($0.60)	($0.71)	($0.56)	($0.42)	$0.82	($0.84)	($0.69)	$0.41	($0.51)
Adjusted Weighted Average Basic Shares Outstanding	18.37M	18.14M	18.62M	18.95M	18.93M	18.84M	18.49M	18.59M	18.61M	18.77M
Adjusted Diluted Earnings per Share	($0.69)	($0.60)	($0.71)	($0.56)	($0.42)	$0.82	($0.84)	($0.69)	$0.41	($0.51)
Adjusted Weighted Average Diluted Shares Outstanding	18.37M	18.14M	18.62M	18.95M	18.93M	18.84M	18.49M	18.59M	18.78M	18.77M
Adjusted Basic & Diluted Earnings per Share	($0.69)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	18.31M	18.93M	18.94M	18.96M	18.87M	19.04M	18.59M	18.62M	18.59M	18.57M
Normalized Net Operating Profit after Tax (NOPAT)	-8.62	-8.25	-9.60	-9.48	-9.94	-13	-11	-9.19	-7.15	-8.75
Normalized NOPAT Margin	-2,239.64%	-2,462.96%	-2,866.45%	-2,382.29%	-1,719.84%	-2,114.96%	-689.08%	-592.59%	-456.30%	-694.17%
Pre Tax Income Margin	-3,195.58%	-3,207.16%	-3,879.40%	-2,620.10%	-1,351.21%	2,661.02%	-937.84%	-808.25%	477.39%	-757.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-32.04%	-39.88%	-45.70%	-41.38%	-26.10%	-50.40%	-104.94%	-193.33%	80.61%	-270.33%

Frequently Asked Questions About Anterix's Financials

When does Anterix's fiscal year end?

According to the most recent income statement we have on file, Anterix's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Anterix's net income changed over the last 2 years?

Anterix's net income appears to be on a downward trend, with a most recent value of -$9.13 million in 2024, falling from -$37.52 million in 2022. The previous period was -$16.32 million in 2023. See Anterix's forecast for analyst expectations on what’s next for the company.

What is Anterix's operating income?

Anterix's total operating income in 2024 was -$10.12 million, based on the following breakdown:

Total Gross Profit: $4.19 million
Total Operating Expenses: $14.31 million

How has Anterix revenue changed over the last 2 years?

Over the last 2 years, Anterix's total revenue changed from $1.08 million in 2022 to $4.19 million in 2024, a change of 286.6%.

How much debt does Anterix have?

Anterix's total liabilities were at $163.86 million at the end of 2024, a 65.9% increase from 2023, and a 78.6% increase since 2022.

How much cash does Anterix have?

In the past 2 years, Anterix's cash and equivalents has ranged from $43.18 million in 2023 to $105.62 million in 2022, and is currently $60.58 million as of their latest financial filing in 2024.

How has Anterix's book value per share changed over the last 2 years?

Over the last 2 years, Anterix's book value per share changed from 10.14 in 2022 to 8.70 in 2024, a change of -14.2%.

Related Companies

This page (NASDAQ:ATEX) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Anterix (ATEX) Financials

Frequently Asked Questions About Anterix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Anterix (ATEX) Financials

Annual Income Statements for Anterix

Quarterly Income Statements for Anterix

Annual Cash Flow Statements for Anterix

Quarterly Cash Flow Statements for Anterix

Annual Balance Sheets for Anterix

Quarterly Balance Sheets for Anterix

Annual Metrics and Ratios for Anterix

Quarterly Metrics and Ratios for Anterix

Frequently Asked Questions About Anterix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools